Eli Lilly's obesity drug Mounjaro will be available through Britain's state health system for some patients from March, after ...

The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

In a recent head-to-head study involving Novo Nordisk 's Wegovy, Zepbound came out on top, resulting in average weight loss ...

Breen对Eli Lilly给予“跑赢大盘”的评级，并设定了1100美元的目标价，这意味着从周三收盘价来看，股价有38.2%的上涨潜力。Eli Lilly目前在糖尿病药物Mounjaro和减肥药物Zepbound等领域处于领先地位。

Britons paying privately for obesity drugs are increasingly choosing Eli Lilly's Mounjaro over Novo Nordisk's Wegovy, online ...

药企正扩展其潜力 ...

FDA has ordered specialty pharmacies and online companies to phase out knockoff versions of Eli Lilly's blockbuster drugs ...

Eli Lilly just gave investors several reasons to cheer.

LONDON, Dec 23 (Reuters) - Eli Lilly's (LLY.N), opens new tab obesity drug Mounjaro will be available through Britain's state health system for some patients from March, after the drugs cost ...

Stock Editorial via Getty Images An expert panel of the EU drug regulator, the European Medicines Agency (EMA), has ...

The obesity drug race is heating up in more ways than one.Eli Lilly, the world’s biggest pharmaceutical company by market ...

Eli Lilly & Co.’s weight-loss and diabetes drug Mounjaro won’t be reclassified as a sleep apnea treatment in Europe, with regulators saying Friday that use of the drug is already covered in ...